Allen C - Search Results

1

Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug.

Bao Z, Yung F, Hickman RJ, Aspuru-Guzik A, Bannigan P, Allen C. Bao Z, et al. Among authors: allen c. Drug Deliv Transl Res. 2024 Jul;14(7):1872-1887. doi: 10.1007/s13346-023-01491-9. Epub 2023 Dec 29. Drug Deliv Transl Res. 2024. PMID: 38158474

2

Polymeric drug delivery systems for localized cancer chemotherapy.

De Souza R, Zahedi P, Allen CJ, Piquette-Miller M. De Souza R, et al. Drug Deliv. 2010 Aug;17(6):365-75. doi: 10.3109/10717541003762854. Drug Deliv. 2010. PMID: 20429844 Free article. Review.

3

Does artificial intelligence have the potential to transform drug formulation development?

Allen C, Bannigan P. Allen C, et al. J Control Release. 2019 Oct;311-312:326-327. doi: 10.1016/j.jconrel.2019.10.019. Epub 2019 Oct 14. J Control Release. 2019. PMID: 31622691 No abstract available.

4

Poly(δ-valerolactone-co-allyl-δ-valerolactone) cross-linked microparticles: Formulation, characterization and biocompatibility.

Bao Z, Jung S, Bufton J, Evans JC, Aguiar DJ, Allen C. Bao Z, et al. Among authors: allen c. J Pharm Sci. 2021 Jul;110(7):2771-2777. doi: 10.1016/j.xphs.2021.03.009. Epub 2021 Mar 16. J Pharm Sci. 2021. PMID: 33737020

5

Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel.

Bufton J, Jung S, Evans JC, Bao Z, Aguiar D, Allen C. Bufton J, et al. Among authors: allen c. Eur J Pharm Sci. 2021 Jul 1;162:105808. doi: 10.1016/j.ejps.2021.105808. Epub 2021 Mar 15. Eur J Pharm Sci. 2021. PMID: 33737226

6

Shifting the Paradigm on Cannabis Safety.

Bannigan P, Evans JC, Allen C. Bannigan P, et al. Among authors: allen c. Cannabis Cannabinoid Res. 2022 Feb;7(1):3-10. doi: 10.1089/can.2020.0003. Epub 2020 Jun 22. Cannabis Cannabinoid Res. 2022. PMID: 33998854 Free PMC article.

7

Machine learning directed drug formulation development.

Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Bannigan P, et al. Among authors: allen c. Adv Drug Deliv Rev. 2021 Aug;175:113806. doi: 10.1016/j.addr.2021.05.016. Epub 2021 May 19. Adv Drug Deliv Rev. 2021. PMID: 34019959 Review.

8

Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro.

Epp-Ducharme B, Dunne M, Fan L, Evans JC, Ahmed L, Bannigan P, Allen C. Epp-Ducharme B, et al. Among authors: allen c. Sci Rep. 2021 May 27;11(1):11103. doi: 10.1038/s41598-021-90585-w. Sci Rep. 2021. PMID: 34045581 Free PMC article.

9

Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes.

Regenold M, Bannigan P, Evans JC, Waspe A, Temple MJ, Allen C. Regenold M, et al. Among authors: allen c. Nanomedicine. 2022 Feb;40:102484. doi: 10.1016/j.nano.2021.102484. Epub 2021 Nov 5. Nanomedicine. 2022. PMID: 34748961

10

Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.

Kok LY, Bannigan P, Sanaee F, Evans JC, Dunne M, Regenold M, Ahmed L, Dubins D, Allen C. Kok LY, et al. Among authors: allen c. Eur J Pharm Sci. 2022 Jan 1;168:106058. doi: 10.1016/j.ejps.2021.106058. Epub 2021 Nov 8. Eur J Pharm Sci. 2022. PMID: 34763088 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,872 results

Search Page

Filters